Treatment of acromegaly patients at the Federal University of Triângulo Mineiro (UFTM): Experience Report

OBJECTIVE: To evaluate the effectiveness of the treatment of acromegaly patients at the Federal University of Triangulo Mineiro. METHODS: Cross-sectional and retrospective study of thirty cases treated over a period of two decades. RESULTS: 17 men (56.7%) aged 14-67 years and 13 women aged 14-86 y...

Full description

Bibliographic Details
Main Authors: Maria de Fátima Borges, Beatriz Hallal Jorge Lara, Janaíne Machado Tomé, Leopoldo Prezia de Araújo, Flávio Cesar Lucas Bugiga, Júlio Cláudio Sousa, Jacqueline Mendes Fonseca Soares, Roberto Alexandre Dezena, Beatriz Pires Ferreira
Format: Article
Language:English
Published: Elsevier España
Series:Clinics
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322017000400218&lng=en&tlng=en
_version_ 1818246239279382528
author Maria de Fátima Borges
Beatriz Hallal Jorge Lara
Janaíne Machado Tomé
Leopoldo Prezia de Araújo
Flávio Cesar Lucas Bugiga
Júlio Cláudio Sousa
Jacqueline Mendes Fonseca Soares
Roberto Alexandre Dezena
Beatriz Pires Ferreira
author_facet Maria de Fátima Borges
Beatriz Hallal Jorge Lara
Janaíne Machado Tomé
Leopoldo Prezia de Araújo
Flávio Cesar Lucas Bugiga
Júlio Cláudio Sousa
Jacqueline Mendes Fonseca Soares
Roberto Alexandre Dezena
Beatriz Pires Ferreira
author_sort Maria de Fátima Borges
collection DOAJ
description OBJECTIVE: To evaluate the effectiveness of the treatment of acromegaly patients at the Federal University of Triangulo Mineiro. METHODS: Cross-sectional and retrospective study of thirty cases treated over a period of two decades. RESULTS: 17 men (56.7%) aged 14-67 years and 13 women aged 14-86 years were analyzed. Twenty-one patients underwent transphenoidal surgery, whichwas associated with somatostatin receptor ligands in 11 patients (39.3%), somatostatin receptor ligands + radiotherapyin 5 patients (17.8%), radiotherapy in 3 patients (10.7%), and radiotherapy + somatostatin receptorligands + cabergoline in 1 patient (3.6%). Additionally, 2 patients underwent radiotherapy and surgeryalone. Six patients received somatostatin receptor ligands before surgery, and 2 were not treated due to refusal and death. Nine patients have died, and 20 are being followed; 13 (65%) have growth hormonelevels o1 ng/mL, and 11 have normal insulin-like growth factor 1 levels. CONCLUSION: The current treatment options enable patients seen in regional reference centers to achieve strict control parameters, which allows them to be treated close to their homes.
first_indexed 2024-12-12T14:45:39Z
format Article
id doaj.art-8ecf8496d90142b7903cad738dcbcc59
institution Directory Open Access Journal
issn 1980-5322
language English
last_indexed 2024-12-12T14:45:39Z
publisher Elsevier España
record_format Article
series Clinics
spelling doaj.art-8ecf8496d90142b7903cad738dcbcc592022-12-22T00:21:07ZengElsevier EspañaClinics1980-532272421822310.6061/clinics/2017(04)05S1807-59322017000400218Treatment of acromegaly patients at the Federal University of Triângulo Mineiro (UFTM): Experience ReportMaria de Fátima BorgesBeatriz Hallal Jorge LaraJanaíne Machado ToméLeopoldo Prezia de AraújoFlávio Cesar Lucas BugigaJúlio Cláudio SousaJacqueline Mendes Fonseca SoaresRoberto Alexandre DezenaBeatriz Pires FerreiraOBJECTIVE: To evaluate the effectiveness of the treatment of acromegaly patients at the Federal University of Triangulo Mineiro. METHODS: Cross-sectional and retrospective study of thirty cases treated over a period of two decades. RESULTS: 17 men (56.7%) aged 14-67 years and 13 women aged 14-86 years were analyzed. Twenty-one patients underwent transphenoidal surgery, whichwas associated with somatostatin receptor ligands in 11 patients (39.3%), somatostatin receptor ligands + radiotherapyin 5 patients (17.8%), radiotherapy in 3 patients (10.7%), and radiotherapy + somatostatin receptorligands + cabergoline in 1 patient (3.6%). Additionally, 2 patients underwent radiotherapy and surgeryalone. Six patients received somatostatin receptor ligands before surgery, and 2 were not treated due to refusal and death. Nine patients have died, and 20 are being followed; 13 (65%) have growth hormonelevels o1 ng/mL, and 11 have normal insulin-like growth factor 1 levels. CONCLUSION: The current treatment options enable patients seen in regional reference centers to achieve strict control parameters, which allows them to be treated close to their homes.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322017000400218&lng=en&tlng=enAcromegalyGigantismTreatmentOutcome
spellingShingle Maria de Fátima Borges
Beatriz Hallal Jorge Lara
Janaíne Machado Tomé
Leopoldo Prezia de Araújo
Flávio Cesar Lucas Bugiga
Júlio Cláudio Sousa
Jacqueline Mendes Fonseca Soares
Roberto Alexandre Dezena
Beatriz Pires Ferreira
Treatment of acromegaly patients at the Federal University of Triângulo Mineiro (UFTM): Experience Report
Clinics
Acromegaly
Gigantism
Treatment
Outcome
title Treatment of acromegaly patients at the Federal University of Triângulo Mineiro (UFTM): Experience Report
title_full Treatment of acromegaly patients at the Federal University of Triângulo Mineiro (UFTM): Experience Report
title_fullStr Treatment of acromegaly patients at the Federal University of Triângulo Mineiro (UFTM): Experience Report
title_full_unstemmed Treatment of acromegaly patients at the Federal University of Triângulo Mineiro (UFTM): Experience Report
title_short Treatment of acromegaly patients at the Federal University of Triângulo Mineiro (UFTM): Experience Report
title_sort treatment of acromegaly patients at the federal university of triangulo mineiro uftm experience report
topic Acromegaly
Gigantism
Treatment
Outcome
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322017000400218&lng=en&tlng=en
work_keys_str_mv AT mariadefatimaborges treatmentofacromegalypatientsatthefederaluniversityoftriangulomineirouftmexperiencereport
AT beatrizhallaljorgelara treatmentofacromegalypatientsatthefederaluniversityoftriangulomineirouftmexperiencereport
AT janainemachadotome treatmentofacromegalypatientsatthefederaluniversityoftriangulomineirouftmexperiencereport
AT leopoldopreziadearaujo treatmentofacromegalypatientsatthefederaluniversityoftriangulomineirouftmexperiencereport
AT flaviocesarlucasbugiga treatmentofacromegalypatientsatthefederaluniversityoftriangulomineirouftmexperiencereport
AT julioclaudiosousa treatmentofacromegalypatientsatthefederaluniversityoftriangulomineirouftmexperiencereport
AT jacquelinemendesfonsecasoares treatmentofacromegalypatientsatthefederaluniversityoftriangulomineirouftmexperiencereport
AT robertoalexandredezena treatmentofacromegalypatientsatthefederaluniversityoftriangulomineirouftmexperiencereport
AT beatrizpiresferreira treatmentofacromegalypatientsatthefederaluniversityoftriangulomineirouftmexperiencereport